BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Collan J, Kapanen M, Mäkitie A, Nyman H, Joensuu H, Tenhunen M, Saarilahti K. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival. Acta Oncol 2012;51:735-42. [PMID: 22150115 DOI: 10.3109/0284186X.2011.640348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Guo Q, Xiao N, Xu H, Zong J, Xiao Y, Lu T, Xu Y, Wang B, Chen B, Pan J, Lin S. Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline. Radiother Oncol 2021;167:239-43. [PMID: 34973279 DOI: 10.1016/j.radonc.2021.12.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jackson JE, Anderson NJ, Wada M, Schneider M, Poulsen M, Rolfo M, Fahandej M, Gan H, Joon DL, Khoo V. Clinical and dosimetric risk stratification for patients at high-risk of feeding tube use during definitive IMRT for head and neck cancer. Tech Innov Patient Support Radiat Oncol 2020;14:1-10. [PMID: 32154393 DOI: 10.1016/j.tipsro.2020.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Gupta DK, Chugh R, Singh SK, Pati S. Use of the facial artery-based cutaneous island flap (melo-labial flap) for reconstruction of the neopharynx following total laryngectomy: a novel technique. BMJ Case Rep 2019;12:e230712. [PMID: 31383687 DOI: 10.1136/bcr-2019-230712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Hoyne C, Dreosti M, Shakeshaft J, Baxi S. Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective study. J Med Radiat Sci 2017;64:125-30. [PMID: 28240447 DOI: 10.1002/jmrs.203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Tuomikoski L, Kapanen M, Collan J, Keyriläinen J, Saarilahti K, Loimu V, Seppälä T, Tenhunen M. Toward a more patient-specific model of post-radiotherapy saliva secretion for head and neck cancer patients. Acta Oncol 2015;54:1310-6. [PMID: 26203929 DOI: 10.3109/0284186X.2015.1067717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Cuaron J, Rao S, Wolden S, Zelefsky M, Schupak K, Mychalczak B, Lee N. Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy. Head Neck 2016;38 Suppl 1:E426-31. [PMID: 25581274 DOI: 10.1002/hed.24013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
7 Gensheimer MF, Liao JJ, Garden AS, Laramore GE, Parvathaneni U. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Radiat Oncol 2014;9:255. [PMID: 25424729 DOI: 10.1186/s13014-014-0255-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
8 Chen J, Ou D, He X, Hu C. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. Int J Clin Oncol 2014;19:998-1004. [PMID: 24337503 DOI: 10.1007/s10147-013-0650-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
9 Chajon E, Lafond C, Louvel G, Castelli J, Williaume D, Henry O, Jégoux F, Vauléon E, Manens JP, Le Prisé E, de Crevoisier R. Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control. Radiat Oncol 2013;8:132. [PMID: 23721062 DOI: 10.1186/1748-717X-8-132] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]